Gilles Peytavin

36PUBLICATIONS
76CO-AUTHORS
PharmacogenomicsFrench languageRegenerative medicine (incl. stem cells)Gene and molecular therapyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Oct 07, 2026
Efficacy and safety of switching to once-daily oral doravirine plus raltegravir in virologically suppressed people with HIV-1: a randomized, open-label, multicentre phase 2 study (DORAL).

|Aug 25, 2026
Lenacapavir Use in France: A National, Observational Study (LENAddOn).

|Aug 19, 2026
A French National Real-World Survey of People With Multiresistant HIV-1 Viruses Receiving an Antiretroviral Regimen Including Fostemsavir or Ibalizumab.

|Jun 22, 2026
Effectiveness and Safety of Lenacapavir-Containing Regimens in Highly Experienced HIV-Infected Patients With Multidrug Resistance: Real-world Results From the French Compassionate Use Program a.

|Jun 22, 2026
Add-on efficacy of doravirine in PLWHIV with virological failure and low-level viremia.

|May 22, 2026
External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected Patients.

Pageof 6

Frequent Collaborators

13 joint publications

Minh-Patrick Le

6 joint publications

Jade Ghosn

6 joint publications

Romain Palich

5 joint publications

Marc Wirden